The QuickVue SARS Antigen Test detects SARS-CoV-2 antigens directly from anterior nares swab specimens. The QuickVue SARS antigen test provides accurate and reliable results in 10 minutes, allowing for COVID-19 testing of symptomatic patients within the first five days of symptoms and asymptomatic patients when tested serially.
Healthcare professionals can purchase the QuickVue SARS antigen test through select authorized distributors.
Features & benefits
Dipstick test format means no instrument necessary.
Two-color easy to read and interpret results.
Specifications
Kit storage conditions - Room temperature (15°C to 30°C/59°F to 86°F)
Internal controls - Included
External controls - Positive and negative included
PPA (Reference Extracted SARS-CoV-2 RT-PCR Assay) - 96.6%
NPA (Reference Extracted SARS-CoV-2 RT-PCR Assay) - 99.3%
CLIA complexity - Waived*
*Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.